Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)-Reference-Cited by-同舟云学术

Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)

Published:2011 Issue:1 Volume:10 Page:94
ISSN:1476-511X
Container-title:Lipids in Health and Disease
language:en
Short-container-title:Lipids Health Dis

Author:

Mata Nelva,Alonso Rodrigo,Badimón Lina,Padró Teresa,Fuentes Francisco,Muñiz Ovidio,Perez-Jiménez Francisco,López-Miranda José,Díaz Jose L,Vidal Jose I,Barba A,Piedecausa Mar,Sanchez Juan F,Irigoyen Luis,Guallar Eliseo,Ordovas José M,Mata Pedro

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference12 articles.

1. Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform

2. Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors

3. Phenotypic variability in familial hypercholesterolaemia: an update

4. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

5. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study;The Lancet Diabetes & Endocrinology;2024-09

2. Effectiveness of cascade screening for elevated lipoprotein(a), an underdiagnosed family disorder;Current Opinion in Lipidology;2024-08-27

3. Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry;Journal of Cardiovascular Medicine;2024-03-20

4. Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study;Atherosclerosis;2024-03

5. Unveiling Familial Hypercholesterolemia—Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy;International Journal of Molecular Sciences;2024-01-29